High expression of GLUT1, encoded by SLC2A1, is associated with different types of malignancies, especially those driven by oncogenic KRAS and BRAF mutations or loss of p53, and thereby contributes to the increased proliferation of cancer cells [7–9]. Here, SLC2A1 is linked to cancer.